Clinical implications of the intrinsic molecular subtypes in hormone receptor-positive and HER2-negative metastatic breast cancerClaudette Falato, Aleix Prat|Cancer Treatment Reviews|2022Cited by 64
Molecular Mechanism and Clinical Implications of Endocrine Therapy Resistance in Breast CancerGrazia Arpino, Sabino De Placido, Claudette Falato et al.|Oncology|2009Cited by 58
Taxane-based adjuvant therapy for early breast cancer (EBC): A meta-analysis of the predictive effect of ER and HER2 status.Michelino De Laurentiis, Sabino De Placido, Mario Giuliano et al.|Journal of Clinical Oncology|2010Cited by 0
Author Index Vol. 77, Suppl. 1, 2009Antônio Rossi, Sabino De Placido, Nicola Normanno et al.|Oncology|2009Cited by 0